 CHIR-090 |
|||
| B1852-5 | Biovision | EUR 207 | |
 CHIR-124 |
|||
| E1KS2683 | EnoGene | 2mg1 PHYSICAL AND CHEMICAL PROPERTIES | EUR 325 |
 CHIR-99021 |
|||
| HY-10182 | MedChemExpress | 10mg | EUR 173 |
 CHIR-98014 |
|||
| HY-13076 | MedChemExpress | 50mg | EUR 753 |
CHIR-124 |
|||
| HY-13263 | MedChemExpress | 50mg | EUR 670 |
CHIR-090 |
|||
| HY-15460 | MedChemExpress | 50mg | EUR 1359 |
CHIR-090 |
|||
| A3307-10 | ApexBio | 10 mg | EUR 382 |
|
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria. |
|||
CHIR-090 |
|||
| A3307-200 | ApexBio | 200 mg | EUR 2716 |
|
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria. |
|||
CHIR-090 |
|||
| A3307-5 | ApexBio | 5 mg | EUR 254 |
|
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria. |
|||
CHIR-090 |
|||
| A3307-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 253 |
|
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria. |
|||
CHIR-090 |
|||
| A3307-50 | ApexBio | 50 mg | EUR 1225 |
|
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria. |
|||
CHIR-124 |
|||
| A8394-25 | ApexBio | 25 mg | EUR 340 |
|
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M. |
|||
CHIR-124 |
|||
| A8394-5 | ApexBio | 5 mg | EUR 151 |
|
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M. |
|||
CHIR-124 |
|||
| A8394-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 160 |
|
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M. |
|||
CHIR-124 |
|||
| A8394-50 | ApexBio | 50 mg | EUR 537 |
|
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M. |
|||
CHIR-98014 |
|||
| A8395-10 | ApexBio | 10 mg | EUR 212 |
|
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1]. |
|||
CHIR-98014 |
|||
| A8395-25 | ApexBio | 25 mg | EUR 374 |
|
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1]. |
|||
CHIR-98014 |
|||
| A8395-5 | ApexBio | 5 mg | EUR 148 |
|
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1]. |
|||
CHIR-98014 |
|||
| A8395-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 197 |
|
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1]. |
|||
CHIR-98014 |
|||
| A8395-50 | ApexBio | 50 mg | EUR 595 |
|
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1]. |
|||
 CHIR 99021 |
|||
| 1677-100 | Biovision | Ask for price | |
CHIR 99021 |
|||
| 1677-25 | Biovision | EUR 892 | |
CHIR 99021 |
|||
| 1677-5 | Biovision | EUR 311 | |
CHIR-98014 |
|||
| 2595-1 | Biovision | EUR 142 | |
CHIR-98014 |
|||
| 2595-5 | Biovision | EUR 414 | |
 CHIR 99021 trihydrochloride |
|||
| B5779-10 | ApexBio | 10 mg | EUR 224 |
CHIR 99021 trihydrochloride |
|||
| B5779-25 | ApexBio | 25 mg | EUR 441 |
CHIR 99021 trihydrochloride |
|||
| B5779-5 | ApexBio | 5 mg | EUR 145 |
CHIR 99021 trihydrochloride |
|||
| B1199-25 | Biovision | EUR 865 | |
CHIR 99021 trihydrochloride |
|||
| B1199-5 | Biovision | EUR 294 | |
) CHIR-99021 (CT99021) |
|||
| E1KS1263 | EnoGene | 2mg | EUR 325 |
) RAF265 (CHIR-265) |
|||
| E1KS2161 | EnoGene | 10mg | EUR 1504 |
) CHIR-99021 (monohydrochloride) |
|||
| HY-10182A | MedChemExpress | 50mg | EUR 725 |
) CHIR-99021 (trihydrochloride) |
|||
| HY-10182B | MedChemExpress | 50mg | EUR 725 |
CHIR-99021 (CT99021) |
|||
| A3011-10 | ApexBio | 10 mg | EUR 171 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) |
|||
| A3011-100 | ApexBio | 100 mg | EUR 693 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) |
|||
| A3011-25 | ApexBio | 25 mg | EUR 293 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) |
|||
| A3011-5 | ApexBio | 5 mg | EUR 131 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) |
|||
| A3011-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 166 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) |
|||
| A3011-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
 Ezsolution? CHIR-98014 |
|||
| 2639-1 | Biovision | EUR 153 | |
 HCl) CHIR-99021 (CT99021) HCl |
|||
| A8396-10 | ApexBio | 10 mg | EUR 171 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) HCl |
|||
| A8396-100 | ApexBio | 100 mg | EUR 693 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) HCl |
|||
| A8396-25 | ApexBio | 25 mg | EUR 293 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) HCl |
|||
| A8396-5 | ApexBio | 5 mg | EUR 131 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) HCl |
|||
| A8396-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 142 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
CHIR-99021 (CT99021) HCl |
|||
| A8396-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?). |
|||
 CHIR 98014, GSK-3 Inhibitor |
|||
| BC214-005 | GenDepot | 5 mg | EUR 313 |
CHIR 98014, GSK-3 Inhibitor |
|||
| BC214-010 | GenDepot | 10 mg | EUR 381 |
CHIR 98014, GSK-3 Inhibitor |
|||
| BC214-050 | GenDepot | 50 mg | EUR 874 |
) Dovitinib (TKI-258, CHIR-258) |
|||
| A2168-25 | ApexBio | 25 mg | EUR 224 |
|
Description: Dovitinib (TKI258, CHIR-258) is a multitargeted receptor tyrosine kinase inhibitor against FLT3, KIT, FGFR, VEGFR, PDGFR? and PDGFR? with IC50 of 1 nM, 2 nM, 8-9 nM, 8-13 nM , 210 nM and 27nM, respectively [1]. |
|||
Dovitinib (TKI-258, CHIR-258) |
|||
| A2168-5 | ApexBio | 5 mg | EUR 108 |
|
Description: Dovitinib (TKI258, CHIR-258) is a multitargeted receptor tyrosine kinase inhibitor against FLT3, KIT, FGFR, VEGFR, PDGFR? and PDGFR? with IC50 of 1 nM, 2 nM, 8-9 nM, 8-13 nM , 210 nM and 27nM, respectively [1]. |
|||
 CHIR 99021, GSK-3 Inhibitor , HCl |
|||
| BC213-005 | GenDepot | 5 mg | EUR 286 |
CHIR 99021, GSK-3 Inhibitor , HCl |
|||
| BC213-025 | GenDepot | 25 mg | EUR 847 |
 CHIR 99021, GSK-3 Inhibitor , Free Base |
|||
| BC212-002 | GenDepot | 2 mg | EUR 178 |
CHIR 99021, GSK-3 Inhibitor , Free Base |
|||
| BC212-005 | GenDepot | 5 mg | EUR 265 |
CHIR 99021, GSK-3 Inhibitor , Free Base |
|||
| BC212-010 | GenDepot | 10 mg | EUR 315 |
CHIR 99021, GSK-3 Inhibitor , Free Base |
|||
| BC212-025 | GenDepot | 25 mg | EUR 394 |
CHIR 99021, GSK-3 Inhibitor , Free Base |
|||
| BC212-100 | GenDepot | 100 mg | EUR 887 |